Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Intimate Partner Violence and Telemedicine Usage and Satisfaction Early in the COVID-19 Pandemic

Megha G. Fatabhoy, Guohao Zhu, Aurianna Lajaunie, Jill R. Schneiderhan and Jennifer Pierce
The Journal of the American Board of Family Medicine August 2023, jabfm.2023.230021R1; DOI: https://doi.org/10.3122/jabfm.2023.230021R1
Megha G. Fatabhoy
From the Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA (MGF, GZ, AL, JP); Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA (JRS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guohao Zhu
From the Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA (MGF, GZ, AL, JP); Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA (JRS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurianna Lajaunie
From the Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA (MGF, GZ, AL, JP); Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA (JRS).
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill R. Schneiderhan
From the Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA (MGF, GZ, AL, JP); Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA (JRS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Pierce
From the Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA (MGF, GZ, AL, JP); Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA (JRS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: COVID-19 has transformed the landscape of telemedicine utilization, shifting from predominantly in-person services to increased virtual encounters. Although telemedicine offers increased accessibility for medical care, many advocates voice concern about utilization and satisfaction with these services among individuals who experience intimate partner violence (IPV) given the unique practical, mental, and physical health challenges many face.

Objective: The purpose of the present study was to evaluate differences in telemedicine utilization and satisfaction, as well as global health and perceived loneliness, among data-driven patterns of IPV during the early phases of the pandemic.

Methods: In this longitudinal survey study, participants first completed an online survey between May 2019 and February 2020 that assessed social, psychological, and physical functioning, as well as emotional and physical IPV. A follow-up survey sent in May 2020 assessed recent telemedicine use and satisfaction, as well as response to the COVID-19 pandemic.

Results: Latent class analysis favored 4 classes of IPV that differed based on severity and features of IPV experienced. Although all 4 classes reported high satisfaction with telemedicine, individuals reporting low IPV had the highest satisfaction with telemedicine and the lowest rates of telemedicine utilization. Individuals who experienced IPV, particularly multiple forms of emotional and physical IPV, reported high physical and social concerns and perceived stress.

Conclusions: Clinicians using telemedicine should be aware of the multiple challenges faced by individuals experiencing IPV and take additional steps to ensure their needs are met in a safe way. These results have potentially important clinical and policy implications.

  • COVID-19
  • Intimate Partner Violence
  • Loneliness
  • Longitudinal Studies
  • Pandemics
  • Personal Satisfaction
  • Telemedicine

Introduction

COVID-19 has transformed the landscape of health care utilization, shifting from predominantly in-person services to increased delivery of telemedicine services.1 Early in the pandemic, telemedicine demonstrated lower no-show rates and similar patient satisfaction rates when compared with in-person visits.2 Although COVID-19 necessitated the rapid shift to telemedicine, its early presumed success has made its continuation tenable and, in many ways, desirable.3 Indeed, telemedicine offers increased accessibility and the potential for needed care despite potential barriers, such as limited time, lack of transportation, and deficient support (eg, childcare).4⇓–6 However, although telemedicine has touted numerous advantages over in-person care, many advocates have voiced concern about utilization and satisfaction with telemedicine services among individuals who experience intimate partner violence (IPV).6

IPV victims face unique challenges that may affect telemedicine utilization and satisfaction. IPV victims may have been unwilling and unable to access medical care within their homes via telemedicine due to the possibility of undue influence from coercive partners and lack of privacy.7 Yet, the story is likely more complex. COVID-19 led to a sense of loneliness and increased health concerns among many individuals,8⇓–10 and this was likely amplified for IPV victims.11 Many of the COVID-19 social distancing measures mirrored the isolation imposed by IPV, including restricting visitors, having to stay home, and limiting visits with family and friends, which may have led to a profound sense of loneliness11 and further increased the risk of IPV (“the pandemic paradox”).12⇓⇓–15 The feelings of intense loneliness may have impacted utilization and satisfaction with telemedicine, although it is unclear how. On one hand, IPV victims may have appreciated the opportunity to connect, albeit remotely.16 On the other hand, the perceived danger imposed by connecting within the home and inability to meet in person and have private contact with a health care provider may have been restrictive and inadequate. In addition, IPV victims often report greater co-occurring physical and mental health concerns, increasing their need for health care more generally.17⇓⇓–20 Pre-existing and exacerbated health-related concerns could, in turn, have contributed to increased need for telemedicine utilization early in the COVID-19 pandemic among IPV victims, although, again, the impact on satisfaction is unclear.

When considering the impact of IPV on telemedicine utilization and satisfaction, it is important to acknowledge the complexity and multifaceted nature of IPV.21 Previous research has attempted to tackle this complexity by evaluating patterns of IPV.19,21⇓⇓–24 The present study considered patterns of psychological and physical IPV, which provides the opportunity to explore the important dimensions of violence, control, and intimidation.21,25 Previous research suggests that particular patterns have unique consequences on health outcomes. In general, patterns with more types or more severe violence have the worst impact on psychological and physical health19,21,22 and may, in turn, be differentially associated with telemedicine utilization and satisfaction.20

COVID-19 rapidly moved many individuals into isolation, which may have amplified the impact of IPV and its effect on health care utilization and satisfaction. A nuanced evaluation of various patterns of psychological and physical IPV and their association with telemedicine utilization and satisfaction is imperative for future clinical and policy decisions – who might we miss, and who might we fail.6 The purpose of the present study was to address this gap in the literature by evaluating the association between IPV history and telemedicine utilization and satisfaction early in the COVID-19 pandemic. The aims of the present study were to explore whether there were differences in telemedicine utilization, satisfaction, global health, and perceived loneliness among data-driven patterns of IPV.

Methods

Participants and Procedure

In this longitudinal survey study, Michigan Medicine patients originally completed an online survey (Pain and Social Experiences [PASE] Study26) between May 2019 and February 2020. The original survey (hereafter referred to as the “baseline survey”) assessed social, psychological, and physical functioning, as well as emotional and physical IPV. On March 23, 2020, the State of Michigan issued a “Stay Home, Stay Safe” order requiring individuals to stay home except for essential business. The order was extended through June 1, 2020. PASE study participants were recruited from May 13, 2020, through May 27, 2020, for a follow-up survey (hereafter referred to as the “COVID-19 survey”) to assess response to the COVID-19 pandemic and current functioning.

Measures

Demographics

Participants self-reported gender, age, education, and race. Gender included 1 (Women) and 0 (Men). Education was recoded to include 1 (Any college education) and 0 (Less than college education). Race was recoded to include 1 (White) and 0 (non-White).

Intimate Partner Violence

Emotional IPV was assessed using the 28-item Multidimensional Measure of Emotional Abuse25 and physical IPV was assessed using the 8-item physical abuse subscale of the Conflict Tactics Scale.27 Participants were asked to indicate how often their partner had engaged in specific behaviors. Emotional abuse behaviors include restrictive engulfment (eg, “Secretly searched through the other person’s belongings”), denigration (eg, “Called the other person worthless”), hostile withdrawal (eg, “Acted cold or distant when angry”), and dominance/intimidation (eg, “Threatened to hit the other person”). Examples of physical IPV include “Pushed, grabbed, or shoved the other one” and “Beat up the other one.” In the present study, we evaluated whether this ever happened with a current partner. Thus, the scores were dichotomized to include 1 (Ever happened with current partner) and 0 (Never happened with current partner).

Perceived Loneliness

Perceived loneliness was evaluated with a modified version of the 5-item Patient Reported Outcomes Measurement Information System (PROMIS) Toolbox Item Bank v2.0 Loneliness (Ages 18+). The measure was modified by asking participants to rank how often they felt certain feelings since the COVID-19 response began (since March 15, 2020). Example items include “I feel alone and apart from others” and “I feel left out.” Response options ranged from 1 (Never) to 5 (Always). A sum score was calculated and converted to t-values according to guidelines set forth by the Patient Reported Outcomes Measurement Information System (PROMIS).

General Health

General health was evaluated by the PROMIS-Preference (PROPr) summary score.28 PROPr is a preference-based health utility score and is calculated from 7 PROMIS domains: cognitive function, depression, fatigue, pain interference, physical functioning, sleep disturbance, and ability to participate in social roles. The lowest possible score is -0.022 (health-related quality of life viewed as worse than dead) and the highest possible score is 1 (full health).

Telemedicine Utilization

In the present study, telemedicine was defined as video and telephone calls with your doctor and/or other medical providers that are similar to other clinical visits but occur over video or telephone. Participants were asked: “Since the COVID-19 pandemic started (from March 15 to now), approximately how many times have you used telemedicine?” Response options included 0 to More than 20. For the present study, scores were dichotomized. As such, response options for the current study include 0 (No telemedicine utilization) and 1 (Telemedicine utilization).

Satisfaction with Telemedicine

After questions regarding utilization, participants who indicated any telemedicine utilization since COVID-19 were asked: “Overall, how satisfied have you been with your experience using telemedicine?” Response options ranged from 0 (Not at all satisfied) to 10 (Completely satisfied).

Post-Hoc Analysis Measures

Perceived Emotional Support

Perceived emotional support was assessed in the baseline and COVID-19 surveys using the 4-item PROMIS Item Bank v2.0 Emotional Support – Short Form 4a. In the baseline survey, participants were asked to respond to each item without reference to a specific time frame. In the COVID-19 survey, the measure was modified such that participants were asked to consider how they felt about other people since the COVID-19 response began (since March 15, 2020). Example items include: “I have someone who will listen to me when I need to talk” and “I have someone to confide in or talk to about myself or my problems.” Response options ranged from 1 (Never) to 5 (Always). A sum score was calculated and converted to t-values according to guidelines set forth by PROMIS. A difference score was also calculated to assess change in perceived emotional support from the baseline survey to the COVID-19 survey (Time 2 – Time 1). Thus, positive scores indicate an increase in perceived emotional support and negative values indicate a decrease in perceived emotional support.

Perceived Ostracism

Perceived ostracism was assessed with 5 items modified from previous work on ostracism.29 Participants were asked to consider their experiences with other people since COVID-19 began (since March 15, 2020). Example items include: “Treat you as though you are invisible” and “Have ignored you.” Response options ranged from 1 (Never) to 5 (Always). A sum score was calculated.

Perceived Stress

Perceived stress was assessed in the baseline and COVID-19 surveys using the 10-item Perceived Stress Scale.30 In both surveys, participants were asked to consider how often they felt a certain way in the last month. Example items include: “Been upset because of something that happened unexpectedly” and “Felt that you were unable to control the important things in your life.” Response options ranged from 0 (Never) to 4 (Very often). A sum score was calculated. A difference score was also calculated to assess change in perceived stress from the baseline survey to the COVID-19 survey (Time 2 – Time 1). Thus, positive scores indicate an increase in perceived stress and negative values indicate a decrease in perceived stress.

COVID-19 Concerns

Participants were presented with numerous potential concerns related to COVID-19 and asked to consider how worried they were about each situation. In the present study, we focused on 4 potential concerns: “Becoming socially isolated”; “Loss of social support”; “Worsening of my underlying medical problems”; and “Worsening of my mental health.” Response options ranged from 1 (Not at all worried) to 5 (Very worried).

Data Analyses

Analyses were restricted to individuals who indicated that they were married in the baseline survey (n = 107) regardless of their past IPV experiences. We further determined that any experience of IPV from a marital partner across the span of the relationship was a better measure compared with past year IPV or lifetime experiences outside of that particular relationship. This was done for 3 reasons. First, we included individuals in marital relationships because we assumed some level of stability from the baseline survey to the COVID-19 survey. Second, we assumed that individuals who experienced IPV in their marital relationships would continue to experience IPV, discomfort, or a power imbalance in their relationship in the present. Third, past year IPV would have been 1 year before the baseline survey rather than the COVID-19 survey, and low rates would not necessarily reflect recent events from the time of COVID-19 or the overall relationship dynamic. Patterns of IPV were first evaluated using latent class analysis across the 36 dichotomous emotional and physical IPV variables. Two variables were not endorsed by any participants and were removed from the models (ie, “Threatened with a knife or gun” and “Used a knife or gun”). In addition, gender was included in the model to control for its effects. Data were fit to models ranging from 2 to 5 groups. The appropriate number of groups was determined according to best model fit criteria, including: Akaike’s Information Criterion (AIC); Bayesian Information Criterion (BIC); and sample-adjusted BIC. We also evaluated the size of the smallest group to ensure that the addition of groups did not overfit the model. AIC and BIC values that are smaller indicate a better fitting model. After determining the best fitting model, participants were then assigned to a single group according to their highest probability score. Frequencies of each form of IPV were then evaluated for each group.

Differences among the IPV groups were then assessed for demographics and the variables of interest. For categorical variables, Pearson's χ2 tests were assessed. Fisher’s Exact Test was used where expected cell counts were less than 5. For continuous variables, Kruskal-Wallis rank sum test was conducted. Because of the small sample sizes across IPV groups, effect sizes were prioritized for interpretation rather than significance of p values. Cohen’s d was calculated for each pairwise comparison. Cohen’s d indicating a medium effect size or higher (d > 50) was interpreted as a meaningful difference between groups. All analyses were conducted using R 4.2.1.

Results

Latent class analysis favored 4 classes of participants. See Table 1. As show in Table 2, Class 1 (n = 42) featured moderate levels of emotional IPV, particularly behaviors indicative of restrictive engulfment and hostile withdrawal. Class 2 (n = 24) featured similar levels of restrictive engulfment and denigration compared with Class 1 but showed higher levels of hostile withdrawal and some forms of dominance/intimidation. Class 3 (n = 14) exhibited nonzero frequencies for all forms of IPV, including high levels of restrictive engulfment, denigration, hostile withdrawal, dominance/intimidation, and mild forms of physical IPV. Some individuals in Class 3 also experienced severe forms of physical IPV. Class 4 (n = 27) exhibited low frequencies across all forms of IPV.

View this table:
  • View inline
  • View popup
Table 1.

Fit Indices for Latent Class Analyses

View this table:
  • View inline
  • View popup
Table 2.

Prevalence of Abuse Experiences Among Data-Driven Latent Class Analysis Categories of Intimate Partner Violence

Overall descriptive statistics and differences between groups can be found in Table 3. Overall, most individuals identified as female, were middle-aged, were college educated, and identified as White. Nearly half of the sample had utilized telemedicine during the early weeks of COVID-19. Satisfaction with telemedicine was high. Participants reported slightly higher than average levels of loneliness. Overall, global health was midrange.

View this table:
  • View inline
  • View popup
Table 3.

Differences Among Victims of Intimate Partner Violence on Demographic Covariates and Variables of Interest

Differences among victims of IPV suggest that most individuals in each class were female, with a slightly higher proportion identifying as female in Class 2 (Moderate emotional IPV with high hostile withdrawal). Nearly all individuals in Class 1 (Moderate emotional abuse) reported being college educated, whereas roughly 4 out of 5 in Class 2 (Moderate emotional IPV with high hostile withdrawal), and 3 out of 4 in Class 3 (Physical and emotional IPV) and Class 4 (Low IPV) indicated being college educated. Class 4 (Low IPV) had the lowest proportion of individuals who had used telemedicine. Individuals in Class 4 (Low IPV) also exhibited the highest satisfaction with telemedicine, which translated to a large effect compared with the 3 other groups. Individuals in Class 4 also reported the lowest levels of loneliness and highest scores on global health, which both exhibited a medium effect compared with Class 3 (Physical and emotional IPV).

Post-Hoc Analysis

We expanded on the original analyses by evaluating perceived emotional support, perceived ostracism, perceived stress, and COVID-19 concerns related to social and emotional health. See Table 4. Class 3 (Physical and emotional IPV) reported the lowest scores on perceived emotional support. This difference exhibited a medium effect compared with the 3 other groups. However, change in perceived emotional support from baseline to the COVID-19 survey was not substantially different between groups. Class 3 (Physical and emotional IPV) reported the highest scores on perceived ostracism, which exhibited a medium effect compared with Class 1 (Moderate emotional IPV) and Class 4 (Low IPV). Individuals in Class 4 (Low IPV) reported the lowest levels of perceived stress, which exhibited a medium effect compared with the 3 other groups. However, change in perceived stress from baseline to the COVID-19 survey was not substantially different between groups. The groups did not exhibit substantial differences in COVID-19 concerns related to social isolation. Class 2 (Moderate emotional IPV with high hostile withdrawal) and Class 3 (Physical and emotional IPV) reported the highest concerns regarding loss of social support, which exhibited medium effects compared with Class 1 (Moderate emotional IPV) and Class 4 (Low IPV). Class 3 (Physical and emotional IPV) reported the highest concerns about worsening of medical problems, which exhibited a medium effect compared with Class 4 (Low IPV). Finally, Class 2 (Moderate emotional IPV with high hostile withdrawal) reported the highest concerns related to worsening of mental health, which exhibited a medium effect compared with Class 4 (Low IPV).

View this table:
  • View inline
  • View popup
Table 4.

Post-Hoc Differences Among Victims of Intimate Partner Violence on Social Functioning, Stress, and COVID-19 Concerns

Discussion

Health care professionals are an important bridge to support and resources for IPV victims.14,31 However, it is unclear if a shift to telemedicine affords the same opportunities. The COVID-19 pandemic necessitated a rapid shift to telemedicine and, thus, an opportunity to evaluate potential drawbacks for IPV victims. Our findings suggest that health care professionals may frequently see IPV victims through telemedicine visits, but additional protocols should be enacted to ensure it is beneficial for IPV victims.

Our findings align with previous research on IPV such that distinct patterns emerge related to type and severity of IPV.19,21⇓⇓–24 Specifically, our study revealed 4 classes of IPV that varied in emotional and physical abuse. Overall, our findings suggest that individuals experiencing all forms of emotional abuse as well as physical abuse report particularly poor health and the highest social distress, including loneliness, low perceived emotional support, and perceived ostracism. This may be due to the isolation that often occurs in abusive relationships. It is important to note that although emotional abuse might not leave physical traces, it has been found to be harmful to victims’ health and well-being.32,33 Indeed, all IPV classes exhibiting any abuse reported higher levels of stress compared with those reporting low IPV. As such, any form of IPV should be taken seriously by providers.

Our results suggest that many victims of IPV reported telemedicine utilization in the early phases of the pandemic. Indeed, across IPV classes, telemedicine utilization was higher compared with the class exhibiting low IPV. This may be due to the more extensive social and physical health needs among victims of IPV. In addition, COVID-19 presented more concerns for individuals who had experienced IPV, including concerns related to losing social support and decreased psychological and physical health. Furthermore, despite higher utilization, satisfaction with telemedicine among IPV victims was lower compared with those with low IPV, although satisfaction overall was high. This suggests that the needs of IPV victims might not have been adequately addressed in the telemedicine visits that occurred in the early phases of COVID-19. This should inform how telemedicine is implemented going forward.

Clinical Implications

It is recommended clinicians screen for IPV during their telemedicine visits so that individuals who screen positive can be referred for appropriate ongoing services.34 Certain populations, such as women of reproductive age, especially pregnant women, may be important to prioritize given the increased risk of experiencing IPV during pregnancy34,35. In addition, it is crucial that health care professionals ask about IPV directly in a safe and private environment when it is suspected in all populations.36 Yet, telemedicine may lack the needed privacy for such inquiry because the perpetrator may be home with the victims. Individuals may also be reluctant to discuss sensitive topics in front of other individuals, such as children, parents, household helpers, and others aside from the perpetrator37, presenting missed opportunities for appropriate screening and referral to necessary services. Future research should assess whether administering short, structured screening measures (eg, Abuse Assessment Screen38 or Woman Abuse Screening Tool39) privately via the electronic health record increases the likelihood of disclosure if patients are reassured of confidentiality. Furthermore, technology may be used as a tool for coercive control in abusive relationships and, thus, telemedicine may require additional precautions to ensure patient safety.40 To help alleviate such concerns, clinicians may want to consider patient privacy by scheduling visits when an abusive partner is out of the home or at times patients believe they are absolutely safe to discuss their matters openly. Numerous methods have also been proposed to offer discreet communication during telemedicine. For example, Jack and colleagues (2021)40 and Simon and colleagues (2021)7 provide a comprehensive script to prepare for telemedicine visits and respond to IPV disclosures. In addition, alternate forms of communication (eg, Signal for Help campaign)41 offer nonverbal communication cues to elicit help or encourage the use of close-ended questions or other nonverbal responses.15 Establishing a comprehensive protocol to prepare and aid providers is imperative due to the importance of safety of the patient and needed support for the provider during such stressful encounters.

It is also important to recognize the long-term effects of IPV and how this may impact utilization and satisfaction with telemedicine. History of IPV is associated with posttraumatic stress disorder, anxiety, and depression,42 as well as poor health and somatic complaints.43 Individuals who have experienced IPV at some point in their life may be more likely to use telemedicine for ongoing medical care even once the COVID-19 pandemic subsides. Thus, it is necessary to assess long-term satisfaction with telemedicine in this population. Ultimately, if inadequate patient satisfaction is a barrier to the use of telemedicine, this information is relevant to providers who may trial or prioritize other forms of patient care. The present study helps to elucidate which patients may be suitable for the use of telemedicine encounters based on their reported satisfaction.

Limitations

The present study had multiple strengths, including evaluating IPV before COVID-19 and its association with telemedicine utilization and satisfaction during the early phases of the pandemic. However, there are also multiple limitations. Although it was postulated that telemedicine utilization and satisfaction differed between IPV classes due to variations in emotional and physical health needs, future research should further examine causality underlying these relationships to have a better understanding of these outcomes. Because our statistical method was data-driven, each group exhibited some IPV, although group 4 showed little to no IPV. Future research may prioritize classifying individuals manually to obtain a group that reported no IPV. In addition, we restricted the sample to individuals who reported being married in the baseline survey because we assumed marital relationships would be more stable than dating relationships. However, we did not assess whether they were in the same relationship during the COVID-19 survey, so this could not be determined with complete certainty. Evaluating the role of victimization and safety in telemedicine satisfaction and utilization is also important for individuals who are single and in nonmarital and dating relationships and should be investigated in future research. Another potential limitation was that telemedicine during the early stages of COVID-19 may have been perceived positively because access to other forms of social support were particularly restricted. In contrast, telemedicine that occurs when individuals are not forced to isolate may not be viewed as favorably because it is more distant than necessary. Thus, the early months of COVID-19, and all the accompanying fear and distress, formed a unique background to the present study. In addition, at the time of this study, many providers were becoming accustomed to using telemedicine due to necessity and likely did not incorporate the aforementioned safe screening tactics. We did not ask whether providers screened for IPV or perceived safety during the encounters. Satisfaction with telemedicine in this study may have been impacted by whether providers screened for IPV and whether they did so while ensuring the patient’s safety. Future research should consider whether providers asked about or screened for IPV and perceived safety of telemedicine, as well as further evaluate presumed mediators and moderators of these associations.

Individuals who completed the present online survey study evidently had access to online technology. It is important to consider the many who do not have access to such technologies, either due to extreme control by the abusive partner or inability to afford smartphones or computers.40,44 Further information on whether telemedicine visits were conducted via telephone or video could have been useful to determine whether individuals preferred one format or another due to ease of access and/or the format’s perceived safety if individuals are in the near vicinity of their perpetrators. In addition, the individuals who participated in the present study did so after having completed a baseline survey assessing IPV. IPV victims who were willing to complete a follow-up study after providing information regarding history of IPV may be different from those who avoided future participation. Finally, it is also important to recognize the intersectionality of IPV with structural inequities that may impact access to telemedicine.6,16,40 Recent research suggests that race and living in a rural environment impacted telemedicine utilization since COVID-19 onset.45 COVID-19 certainly amplified numerous inequities that already existed, including reduced access to medical care and lack of resources, which would be particularly difficult for IPV victims.6

Conclusion

IPV victims may be frequently seen in telemedicine visits, but additional steps should be taken to ensure their needs are met. In addition to safe disclosure methods, providers should consider additional needs related to social concerns, stress, and physical health. Given the burgeoning use of telemedicine, steps should be taken to prepare for such visits so this complexity can be appropriately and safely addressed.

Notes

  • This article was externally peer reviewed.

  • This is the Ahead of Print version of the article.

  • Funding: This research was supported by a Postdoctoral Translational Scholar Program training grant from the Michigan Institute for Clinical and Health Research (UL1TR002240; PI: George Mashour) awarded to JP. The funder was not involved in study design, data collection, data analysis, or manuscript preparation.

  • Conflict of interest: The authors have no conflicts of interest to report.

  • To see this article online, please go to: http://jabfm.org/content/00/00/000.full.

  • Received for publication January 19, 2023.
  • Revision received May 17, 2023.
  • Accepted for publication May 22, 2023.

References

  1. 1.↵
    1. Knierim K,
    2. Palmer C,
    3. Kramer ES,
    4. et al
    . Lessons learned during COVID-19 that can move telehealth in primary care forward. J Am Board Fam Med 2021;34:S196–S202.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Drerup B,
    2. Espenschied J,
    3. Wiedemer J,
    4. Hamilton L
    . Reduced no-show rates and sustained patient satisfaction of telehealth during the COVID-19 pandemic. Telemed J E Health 2021;27:1409–15.
    OpenUrlCrossRef
  3. 3.↵
    1. Nanda M,
    2. Sharma R
    . A review of patient satisfaction and experience with telemedicine: a virtual solution during and beyond COVID-19 pandemic. Telemed J E Health 2021;27:1325–31.
    OpenUrl
  4. 4.↵
    1. Emerick T,
    2. Alter B,
    3. Jarquin S,
    4. et al
    . Telemedicine for chronic pain in the COVID-19 era and beyond. Pain Med 2020;21:1743–8.
    OpenUrl
  5. 5.↵
    1. Fogarty A,
    2. Savopoulos P,
    3. Seymour M,
    4. et al
    . Providing therapeutic services to women and children who have experienced intimate partner violence during the COVID-19 pandemic: challenges and learnings. Child Abuse Negl 2022;130:105365.
    OpenUrl
  6. 6.↵
    1. Williams EE,
    2. Arant KR,
    3. Leifer VP,
    4. et al
    . Provider perspectives on the provision of safe, equitable, trauma-informed care for intimate partner violence survivors during the COVID-19 pandemic: a qualitative study. BMC Womens Health 2021;21:315.
    OpenUrl
  7. 7.↵
    1. Simon MA
    . Responding to intimate partner violence during telehealth clinical encounters. JAMA 2021;325:2307–8.
    OpenUrl
  8. 8.↵
    1. Killgore WDS,
    2. Cloonan SA,
    3. Taylor EC,
    4. Dailey NS
    . Loneliness: a signature mental health concern in the era of COVID-19. Psychiatry Res 2020;290:113117.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Kibbey MM,
    2. Fedorenko EJ,
    3. Farris SG
    . Anxiety, depression, and health anxiety in undergraduate students living in initial US outbreak “hotspot” during COVID-19 pandemic. Cogn Behav Ther 2021;50:409–21.
    OpenUrl
  10. 10.↵
    1. Özdin S,
    2. Bayrak Özdin Ş
    . Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. Int J Soc Psychiatry 2020;66:504–11.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Goodman LA,
    2. Epstein D
    . Loneliness and the COVID-19 pandemic: implications for intimate partner violence survivors. J Fam Violence 2022;37:767–74.
    OpenUrl
  12. 12.↵
    1. Bradbury-Jones C,
    2. Isham L
    . The pandemic paradox: The consequences of COVID-19 on domestic violence. J Clin Nurs 2020;29:2047–9.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Jetelina KK,
    2. Knell G,
    3. Molsberry RJ
    . Changes in intimate partner violence during the early stages of the COVID-19 pandemic in the USA. Inj Prev 2021;27:93–7.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Sánchez OR,
    2. Vale DB,
    3. Rodrigues L,
    4. Surita FG
    . Violence against women during the COVID-19 pandemic: An integrative review. Int J Gynaecol Obstet Off Obstet 2020;151:180–7.
    OpenUrl
  15. 15.↵
    1. Viero A,
    2. Barbara G,
    3. Montisci M,
    4. Kustermann K,
    5. Cattaneo C
    . Violence against women in the Covid-19 pandemic: a review of the literature and a call for shared strategies to tackle health and social emergencies. Forensic Sci Int 2021;319:110650.
    OpenUrlPubMed
  16. 16.↵
    1. Leite H,
    2. Hodgkinson IR,
    3. Gruber T
    . New development: “Healing at a distance”—telemedicine and COVID-19. Public Money Manag 2020;40:483–5.
    OpenUrl
  17. 17.↵
    1. Dillon G,
    2. Hussain R,
    3. Loxton D,
    4. Rahman S
    . Mental and physical health and intimate partner violence against women: a review of the literature. Int J Fam Med 2013;2013:313909.
    OpenUrl
  18. 18.↵
    1. Campbell J,
    2. Jones AS,
    3. Dienemann J,
    4. et al
    . Intimate partner violence and physical health consequences. Arch Intern Med 2002;162:1157–63.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Dutton MA,
    2. Kaltman S,
    3. Goodman LA,
    4. Weinfurt K,
    5. Vankos N
    . Patterns of intimate partner violence: correlates and outcomes. Violence Vict 2005;20:483–97.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Bonomi AE,
    2. Anderson ML,
    3. Rivara FP,
    4. Thompson RS
    . Health care utilization and costs associated with physical and nonphysical-only intimate partner violence. Health Serv Res 2009;44:1052–67.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Conroy NE,
    2. Crowley CG
    . Extending Johnson’s Typology: additional manifestations of dating violence and coercive control. J Interpers Violence 2022;37:NP13315–NP13341.
    OpenUrl
  22. 22.↵
    1. Carbone-López K,
    2. Kruttschnitt C,
    3. Macmillan R
    . Patterns of intimate partner violence and their associations with physical health, psychological distress, and substance use. Public Health Rep Wash Rep 2006;121:382–92.
    OpenUrl
  23. 23.↵
    1. Dardis CM,
    2. Ahrens C,
    3. Howard RL,
    4. Mechanic MB
    . Patterns of Surveillance, control, and abuse among a diverse sample of intimate partner abuse survivors. Violence Against Women 2021;27:2882–909.
    OpenUrl
  24. 24.↵
    1. Free BL,
    2. Lipinski AJ,
    3. Lewin RK,
    4. Majeed R,
    5. Zakarian RJ,
    6. Beck JG
    . Using a person-centered approach to identify patterns of exposure to intimate partner violence and child abuse in women: associations with mental health. Child Maltreat 2021;26:376–86.
    OpenUrl
  25. 25.↵
    1. Murphy CM,
    2. Hoover SA
    . Measuring emotional abuse in dating relationships as a multifactorial construct. Violence Vict 1999;14:39–53.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Pierce J,
    2. Hassett AL,
    3. Harris RE,
    4. Goesling J,
    5. Brummett CM
    . 4385 The pain and social experiences project: understanding the role of interpersonal trauma in pain. J Clin Trans Sci 2020;4:113.
    OpenUrl
  27. 27.↵
    1. Straus MA
    . Measuring intrafamily conflict and violence: The Conflict Tactics (CT) Scales. J Marriage Fam 1979;41:75–88.
    OpenUrlCrossRef
  28. 28.↵
    1. Dewitt B,
    2. Feeny D,
    3. Fischhoff B,
    4. et al
    . Estimation of a preference-based summary score for the patient-reported outcomes measurement information system: the PROMIS-Preference (PROPr) scoring system. Med Decis Making 2018;38:683–698.
    OpenUrlPubMed
  29. 29.↵
    1. Gilman R,
    2. Carter-Sowell A,
    3. Dewall CN,
    4. Adams RE,
    5. Carboni I
    . Validation of the ostracism experience scale for adolescents. Psychol Assess 2013;25:319–330.
    OpenUrl
  30. 30.↵
    1. Cohen S,
    2. Kamarck T,
    3. Mermelstein R
    . A global measure of perceived stress. J Health Soc Behav 1983;24:385–396.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Bradley NL,
    2. DiPasquale AM,
    3. Dillabough K,
    4. Schneider PS
    . Health care practitioners’ responsibility to address intimate partner violence related to the COVID-19 pandemic. CMAJ 2020;192:E609–E610.
    OpenUrlFREE Full Text
  32. 32.↵
    1. Follingstad D,
    2. Rutledge L,
    3. Berg B,
    4. Hause E,
    5. Polek D
    . The role of emotional abuse in physically abusive relationships. J Fam Viol 1990;5:107–120.
    OpenUrlCrossRef
  33. 33.↵
    1. Williams C,
    2. Richardson DS,
    3. Hammock GS,
    4. Janit AS
    . Perceptions of physical and psychological aggression in close relationships: A review. Aggress Violent Behav 2012;17:489–494.
    OpenUrlCrossRef
  34. 34.↵
    US Preventive Services Task Force. Screening for intimate partner violence, elder abuse, and abuse of vulnerable adults: US Preventive Services Task Force final recommendation statement. JAMA 2018;320:1678–1687.
    OpenUrl
  35. 35.↵
    1. Taillieu TL,
    2. Brownridge DA
    . Violence against pregnant women: prevalence, patterns, risk factors, theories, and directions for future research. Aggress Violent Behav 2010;15:14–35.
    OpenUrlCrossRef
  36. 36.↵
    1. Sprague S,
    2. Bhandari M,
    3. Della Rocca GJ
    , PRAISE Investigatorset al. Prevalence of abuse and intimate partner violence surgical evaluation (PRAISE) in orthopaedic fracture clinics: a multinational prevalence study. Lancet 2013;382:866–876.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Todahl J,
    2. Walters E
    . Universal screening for intimate partner violence: a systematic review. J Marital Fam Ther 2011;37:355–369.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Laughon K,
    2. Renker P,
    3. Glass N,
    4. Parker B
    . Revision of the Abuse Assessment Screen to address nonlethal strangulation. J Obstet Gynecol Neonatal Nurs 2008;37:502–507.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Brown JB,
    2. Lent B,
    3. Brett PJ,
    4. Sas G,
    5. Pederson LL
    . Development of the Woman Abuse Screening Tool for use in family practice. Fam Med 1996;28:422–428.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Jack SM,
    2. Munro-Kramer ML,
    3. Williams JR,
    4. et al
    . Recognising and responding to intimate partner violence using telehealth: practical guidance for nurses and midwives. J Clin Nurs 2021;30:588–602.
    OpenUrl
  41. 41.↵
    Signal for Help. Women’s Funding Network. Accessed November 15, 2022. Available at: https://www.womensfundingnetwork.org/signalforhelp/.
  42. 42.↵
    1. Pill N,
    2. Day A,
    3. Mildred H
    . Trauma responses to intimate partner violence: A review of current knowledge. Aggress Violent Behav 2017;34:178–184.
    OpenUrl
  43. 43.↵
    1. Campbell JC
    . Health consequences of intimate partner violence. Lancet 2002;359:1331–1336.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. El Morr C,
    2. Layal M
    . Effectiveness of ICT-based intimate partner violence interventions: a systematic review. BMC Public Health 2020;20:1372.
    OpenUrl
  45. 45.↵
    1. Hsiao V,
    2. Chandereng T,
    3. Lankton RL,
    4. et al
    . Disparities in telemedicine access: a cross-sectional study of a newly established infrastructure during the COVID-19 pandemic. Appl Clin Inform 2021;12:445–458.
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 37 (6)
The Journal of the American Board of Family Medicine
Vol. 37, Issue 6
November-December 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intimate Partner Violence and Telemedicine Usage and Satisfaction Early in the COVID-19 Pandemic
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Intimate Partner Violence and Telemedicine Usage and Satisfaction Early in the COVID-19 Pandemic
Megha G. Fatabhoy, Guohao Zhu, Aurianna Lajaunie, Jill R. Schneiderhan, Jennifer Pierce
The Journal of the American Board of Family Medicine Aug 2023, jabfm.2023.230021R1; DOI: 10.3122/jabfm.2023.230021R1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intimate Partner Violence and Telemedicine Usage and Satisfaction Early in the COVID-19 Pandemic
Megha G. Fatabhoy, Guohao Zhu, Aurianna Lajaunie, Jill R. Schneiderhan, Jennifer Pierce
The Journal of the American Board of Family Medicine Aug 2023, jabfm.2023.230021R1; DOI: 10.3122/jabfm.2023.230021R1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Practicing Family Medicine in a Pandemic World: Lessons for Telemedicine, Health Care Delivery, and Mental Health Care
  • Google Scholar

More in this TOC Section

  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Successful Implementation of Integrated Behavioral Health
Show more Original Research

Similar Articles

Keywords

  • COVID-19
  • Intimate Partner Violence
  • Loneliness
  • Longitudinal Studies
  • Pandemics
  • Personal Satisfaction
  • Telemedicine

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire